Home/Pan Cancer T/Dr. Rachel Abbott

DR

Dr. Rachel Abbott

Chief Executive Officer

Therapeutic Areas

Pan Cancer T Pipeline

Drug	Indication	Phase
Undisclosed TCR-T Program(s)	Solid Tumors	Preclinical

Leadership Team at Pan Cancer T

Dr. Dora Hammerl

VP R&D, Co-Founder

Dr. Reinout Hesselink

VP Process Development

View full Pan Cancer T profile